HRTX FY 2024 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HRTXHeron Therapeutics, Inc.

$162M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$144M+13.6% YoY

Gross Profit

$106M73.2% margin

Operating Income

-$12M-8.0% margin

Net Income

-$14M-9.4% margin

EPS (Diluted)

$-0.09

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$24M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$233M

Total Liabilities

$267M

Stockholders' Equity

-$34M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$144M	$127M	+13.6%
Gross Profit	$106M	$62M	+70.6%
Operating Income	-$12M	-$111M	+89.6%
Net Income	-$14M	-$111M	+87.7%